Tata Nifty Mid Small Healthcare Index Fund - Regular Plan - Growth
Category: Index Fund
Launch Date: 26-04-2024
AUM:
₹ 219.09 Cr
Expense Ratio
1.15%
Benchmark
NIFTY 100 Equal Weight TRI
ISIN
INF277KA1BD0
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Nitin Bharat Sharma, Rakesh Indrajeet Prajapati
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Tata Nifty Mid Small Healthcare Index Fund - Regular Plan - Growth | 15.08 | - | - |
| NIFTY 100 Equal Weight TRI | 4.59 | 14.54 | 11.83 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
15.1141
Last change
-0.01 (-0.0635%)
Fund Size (AUM)
₹ 219.09 Cr
Performance
18.66% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns
Fund Manager
Nitin Bharat Sharma, Rakesh Indrajeet Prajapati
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 9.36 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 9.3 |
| FORTIS HEALTHCARE LIMITED. EQ | 7.9 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 6.99 |
| GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- | 5.26 |
| ALKEM LABORATORIES LIMITED EQ | 5.17 |
| BIOCON LIMITED EQ | 4.73 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 4.56 |
| IPCA LABORATORIES LIMITED EQ NEW FV RE .1/- | 3.74 |
| Krishna Institute Of Medical Sciences Limited | 3.19 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.06 |